Performance of RMD ResMed | -7.6% in 12m
Compare RMD with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare ResMed with its related Sector/Index XLV
Performance Duell RMD vs XLV
| TimeFrame | RMD | XLV |
|---|---|---|
| 1 Day | -1.30% | -0.34% |
| 1 Week | -0.99% | 1.07% |
| 1 Month | 13.4% | -0.48% |
| 3 Months | 15.9% | -1.06% |
| 6 Months | 43.4% | 11.75% |
| 12 Months | -7.58% | 8.34% |
| YTD | 24.2% | 2.75% |
| Rel. Perf. 1m | 1.24 | |
| Rel. Perf. 3m | 1.62 | |
| Rel. Perf. 6m | 2.35 | |
| Rel. Perf. 12m | -1.50 |
Is ResMed a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, ResMed (NYSE:RMD) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 80.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of May 2024 is 198.19. This means that RMD is currently overvalued and has a potential downside of -6.9% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of May 2024 is 198.19. This means that RMD is currently overvalued and has a potential downside of -6.9% (Sold with Premium).
Is RMD a buy, sell or hold?
- Strong Buy: 7
- Buy: 3
- Hold: 5
- Sell: 1
- Strong Sell: 0
Values above 0%: RMD is performing better - Values below 0%: RMD is underperforming
Compare RMD with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.36% | 13.67% | 24.31% | -34.70% |
| US NASDAQ 100 | QQQ | -5.39% | 13.50% | 24.99% | -44.44% |
| US Dow Jones Industrial 30 | DIA | -4.05% | 12.97% | 27.90% | -25.97% |
| German DAX 40 | DBXD | -4.28% | 12.61% | 22.36% | -22.99% |
| UK FTSE 100 | ISFU | -4.01% | 9.19% | 26.85% | -18.33% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.04% | 10.49% | 42.10% | 5.34% |
| Hongkong Hang Seng | HSI | -4.65% | 6.13% | 43.42% | 7.95% |
| Japan Nikkei 225 | EXX7 | -0.86% | 17.98% | 28.67% | -24.93% |
| India NIFTY 50 | INDA | -0.25% | 14.07% | 26.09% | -33.08% |
| Brasil Bovespa | EWZ | -5.00% | 13.75% | 38.53% | -27.53% |
RMD ResMed vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.40% | 14.92% | 22.29% | -46.78% |
| Consumer Discretionary | XLY | -2.90% | 14.87% | 33.07% | -28.94% |
| Consumer Staples | XLP | -2.99% | 10.28% | 30.48% | -9.93% |
| Energy | XLE | -2.15% | 17.85% | 28.93% | -27.64% |
| Financial | XLF | -3.47% | 14.31% | 19.53% | -37.59% |
| Health Care | XLV | -2.06% | 13.86% | 31.69% | -15.92% |
| Industrial | XLI | -3.57% | 14.26% | 19.65% | -35.10% |
| Materials | XLB | -2.82% | 15.66% | 24.56% | -24.19% |
| Real Estate | XLRE | -3.37% | 17.62% | 34.24% | -10.84% |
| Technology | XLK | -6.44% | 14.04% | 26.45% | -44.19% |
| Utilities | XLU | -5.08% | 6.24% | 25.81% | -13.20% |
| Aerospace & Defense | XAR | -4.28% | 10.98% | 24.14% | -33.36% |
| Biotech | XBI | -3.03% | 14.81% | 15.07% | -12.44% |
| Homebuilder | XHB | -4.15% | 16.23% | 5.91% | -56.90% |
| Retail | XRT | -4.05% | 15.20% | 21.03% | -28.69% |
Does ResMed outperform its market, is RMD a Sector Leader?
No, over the last 12 months ResMed (RMD) made -7.58%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.34%.
Over the last 3 months RMD made 15.85%, while XLV made -1.06%.
No, over the last 12 months ResMed (RMD) made -7.58%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.34%.
Over the last 3 months RMD made 15.85%, while XLV made -1.06%.
| Period | RMD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 13.38% | -0.48% | -0.29% |
| 3 Months | 15.85% | -1.06% | 4.11% |
| 12 Months | -7.58% | 8.34% | 27.12% |